Skip to main content
OpenTrials
Completed

NCT Number: NCT03035136

Retrospective Study on Epidemiology of Colorectal Lesions

Retrospective analysis on colonoscopies in the endoscopy unit of the Lyell McEwin Hospital.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Colonoscopy reports will be manually searched by the investigator to evaluate epidemiology on colorectal lesions.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Colonoscopies performed in Lyell McEwin Hospital between 2010-2016

Exclusion criteria

  • Sigmoidoscopies

Treatment and study plan

Primary outcomes

  1. Adenoma detection rate

    Time frame: Day 1

    Percentage of screening patients with at least one adenomatous lesion found - to be compared between Gastroenterologists and Surgeons and based on scheduling of the procedure

Secondary outcomes

  1. SSA/P detection rate

    Time frame: Day 1

    Percentage of screening patients with at least one SSA/P found - to be compared between Gastroenterologists and Surgeons and based on scheduling of the procedure

  2. Polyp detection rate

    Time frame: Day 1

    Percentage of screening patients with at least one polyp found - to be compared between Gastroenterologists and Surgeons and based on scheduling of the procedure

Sponsors and collaborators

Lead sponsor

Lyell McEwin Hospital

Other Gov

Registry information

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Jan 27, 2017
Registry last updated
Mar 7, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.